Research question | Type | Outcome measures | T0 | T3 | T6 | T9 | After study |
---|---|---|---|---|---|---|---|
1) To what extent do patients use a tailored relapse prevention programme? | Quantitative | Use of the relapse prevention programme (log data) | x | x | x | x | Â |
Case registration form | Â | Â | Â | Â | x | ||
2) What factors influence the use of the programme? | Quantitative | Demographic variables: - Gender - Age - Nationality - Ethnicity - Socioeconomic status - Marital status - Education - Employment status | x | Â | Â | Â | Â |
Clinical variables: - Earlier treatment of depression and/or anxiety - Number of previous episodes - Age of onset of symptoms - Family history of depression and/or anxiety - Estimated risk of relapse - Estimated effect of the programme | x | Â | Â | Â | Â | ||
Self-management strategies | x | Â | Â | x | Â | ||
3) What is the association between usage intensity and course of symptoms? | Quantitative | Use of the relapse prevention programme (log data) | x | x | x | x | Â |
Case registration form | Â | Â | Â | Â | x | ||
BAI | x | x | x | x | Â | ||
ASI | x | x | x | x | Â | ||
IDS-SR | x | x | x | x | Â | ||
WHODAS 2.0 | x | x | x | x | Â | ||
TiC-P | x | x | x | x | Â | ||
Weekly mood and anxiety diary | x | x | x | x | Â | ||
4) What are barriers and facilitators in the implementation of the programme? | Qualitative | Individual interviews | Â | Â | Â | Â | x |
Focus group interview | Â | Â | Â | Â | x | ||
5) How do patients evaluate the programme? | Qualitative | Satisfaction with treatment measure | Â | Â | Â | x | Â |
Individual interviews | Â | Â | Â | Â | x | ||
Focus group interview | Â | Â | Â | Â | x |